Granulocyte-Colony Stimulating Factor (G-CSF)-mobilized, HLA-mismatched donor tumor cells have been shown to enhance CD8+ T cell frequencies, with therapeutic efficacy correlating with the degree of expansion [108]. This evidence concerns the gene CD8A and neoplasm.